Fondaparinux versus Enoxaparin in non–ST-elevation acute coronary syndromes: Short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial

✍ Scribed by Mark J. Sculpher; Greta Lozano-Ortega; Jennifer Sambrook; Stephen Palmer; Orges Ormanidhi; Ameet Bakhai; Marcus Flather; P. Gabriel Steg; Shamir R. Mehta; William Weintraub

• Book ID: 116191717
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 225 KB
• Volume: 157
• Category: Article
• ISSN: 1097-6744
• DOI: 10.1016/j.ahj.2009.02.017